View in EDS

Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.

Saved in:
Bibliographic Details
Title: Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.
Authors: Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit - ISPRO, Florence, Italy., Lee-Ying R; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Patrikidou A; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zanardi E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Rossetti S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., Davidsohn M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Eid M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McClure H; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy., Damassi A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Oliveira TM; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Malgeri A; Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy., Modesti M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Ravi P; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Santini D; Oncology Unit, Umberto I hospital, Rome, Italy., Pignata S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Heng D; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
Corporate Authors: Spartacuss Group
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102185. Date of Electronic Publication: 2024 Aug 09.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39217072
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fotia+G%22">Fotia G</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Saieva+C%22">Saieva C</searchLink>; Cancer Risk Factors and Lifestyle Epidemiology Unit - ISPRO, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Lee-Ying+R%22">Lee-Ying R</searchLink>; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Patrikidou+A%22">Patrikidou A</searchLink>; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Nuzzo+PV%22">Nuzzo PV</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Zanardi+E%22">Zanardi E</searchLink>; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Rossetti+S%22">Rossetti S</searchLink>; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Davidsohn+M%22">Davidsohn M</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Eid+M%22">Eid M</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22El+Zarif+T%22">El Zarif T</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22McClure+H%22">McClure H</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Spinelli+GP%22">Spinelli GP</searchLink>; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Damassi+A%22">Damassi A</searchLink>; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Murianni+V%22">Murianni V</searchLink>; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Vauchier+C%22">Vauchier C</searchLink>; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Oliveira+TM%22">Oliveira TM</searchLink>; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Malgeri+A%22">Malgeri A</searchLink>; Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Modesti+M%22">Modesti M</searchLink>; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mestre+RP%22">Mestre RP</searchLink>; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Valenca+L%22">Valenca L</searchLink>; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Ravi+P%22">Ravi P</searchLink>; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Santini+D%22">Santini D</searchLink>; Oncology Unit, Umberto I hospital, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Pignata+S%22">Pignata S</searchLink>; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22De+Giorgi+U%22">De Giorgi U</searchLink>; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Sweeney+C%22">Sweeney C</searchLink>; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Heng+D%22">Heng D</searchLink>; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Procopio+G%22">Procopio G</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Russo+A%22">Russo A</searchLink>; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Francini+E%22">Francini E</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Spartacuss+Group%22">Spartacuss Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101260955%22">Clinical genitourinary cancer</searchLink> [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102185. <i>Date of Electronic Publication: </i>2024 Aug 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101260955 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215587673%22">15587673 </searchLink><i>NLM ISO Abbreviation: </i>Clin Genitourin Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39217072
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clgc.2024.102185
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102185
    Titles:
      – TitleFull: Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fotia G
      – PersonEntity:
          Name:
            NameFull: Saieva C
      – PersonEntity:
          Name:
            NameFull: Lee-Ying R
      – PersonEntity:
          Name:
            NameFull: Patrikidou A
      – PersonEntity:
          Name:
            NameFull: Nuzzo PV
      – PersonEntity:
          Name:
            NameFull: Zanardi E
      – PersonEntity:
          Name:
            NameFull: Rossetti S
      – PersonEntity:
          Name:
            NameFull: Davidsohn M
      – PersonEntity:
          Name:
            NameFull: Eid M
      – PersonEntity:
          Name:
            NameFull: El Zarif T
      – PersonEntity:
          Name:
            NameFull: McClure H
      – PersonEntity:
          Name:
            NameFull: Spinelli GP
      – PersonEntity:
          Name:
            NameFull: Damassi A
      – PersonEntity:
          Name:
            NameFull: Murianni V
      – PersonEntity:
          Name:
            NameFull: Vauchier C
      – PersonEntity:
          Name:
            NameFull: Oliveira TM
      – PersonEntity:
          Name:
            NameFull: Malgeri A
      – PersonEntity:
          Name:
            NameFull: Modesti M
      – PersonEntity:
          Name:
            NameFull: Mestre RP
      – PersonEntity:
          Name:
            NameFull: Valenca L
      – PersonEntity:
          Name:
            NameFull: Ravi P
      – PersonEntity:
          Name:
            NameFull: Santini D
      – PersonEntity:
          Name:
            NameFull: Pignata S
      – PersonEntity:
          Name:
            NameFull: De Giorgi U
      – PersonEntity:
          Name:
            NameFull: Sweeney C
      – PersonEntity:
          Name:
            NameFull: Heng D
      – PersonEntity:
          Name:
            NameFull: Procopio G
      – PersonEntity:
          Name:
            NameFull: Russo A
      – PersonEntity:
          Name:
            NameFull: Francini E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2024 Oct
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0682
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical genitourinary cancer
              Type: main
ResultId 1